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Midtrimester dilation and evacuation (D&E) versus prostaglandin induction:
A comparison of composite outcomes
Kari A. Whitley, MD; Meredith Rochon, MD; Kevin Trinchere; Wendy Prutsman, MSN, CRNP
Lehigh Valley Health Network, Allentown, Pennsylvania

Abstract:
Objective:

To determine the optimal procedure for midtrimester uterine
evacuation.

Study Design:

We performed a retrospective cohort study of all women
undergoing a planned midtrimester (13 0/7 weeks to 23 6/7
weeks) uterine evacuation procedure at our institution from
1/2005 - 6/2010. Women undergoing D&E by an experienced
provider under continuous ultrasound guidance were
compared with those undergoing a prostaglandin induction.
Women in labor or with cervical insufficiency were excluded.
Medical records were reviewed for maternal demographics,
comorbidities, procedure indications and complications.
The primary outcome was a composite complication rate,
defined as any one of the following events: infection,
transfusion, need for additional surgery, unexpected
admission or readmission to the hospital or uterine/cervical
injury. Student t test, chi square, Mann U Whitney, and
Fisher’s exact test were used as indicated.

Results:

221 women were identified: 94 D&E and 127 induction.
Indications for uterine evacuation included termination for
fetal abnormalities (58%), fetal demise (31%), and other
(11%). Women undergoing D&E were older (32.8±7.0 v.
29.0±6.2 yrs, p<0.001), had an earlier gestational age
(17.4±3.0 v. 19.7±2.3 wks, p<0.001), and were more likely to
have cervical ripening prior to the procedure (86% v. 30%,
p<0.001). There was no difference in parity, insurance class,
BMI, and rate of previous uterine surgery. The composite
complication rate was higher in the induction group (15% v.
28%, p=0.03), although serious complications were rare in
both groups (7% v. 3%, p=0.15). Median length of stay was
significantly shorter in the D&E group (5.7 hrs, range 2.6 241.7 hrs vs. 28.4 hrs, range 11.0 - 173.0 hrs, p<0.001).

Conclusion:

Our data suggest that midtrimester D&E is safer and more
cost effective than prostaglandin induction. While there are
many factors that influence provider and patient preference,
from a systems perspective, D&E may be preferable to
prostaglandin induction for midtrimester uterine evacuation.

Methods:
•	Retrospective cohort study
•	Inclusion criteria: all patients having a planned
midtrimester (13 0/7 weeks - 23 6/7 weeks) uterine
evacuation at Lehigh Valley Health Network via
either ultrasound-guided D&E or prostaglandin
induction of labor from 1/2005 - 6/2010
•	Exclusion criteria: labor, chorioamnionitis, cervical
insufficiency, advanced dilation, first or third
trimester pregnancy
•	Patients were identified by both ICD 9 and
diagnosis codes. Data was collected by review of
medical records.
Table 1. Baseline Maternal Characteristics
D&E
(n=94)

Induction
(n=127)

P-value

32.8 ± 7.0

29.0 ± 6.2

<0.001

Caucasian

80%

73%

Hispanic

11%

21%

African American

1%

4%

Other

9%

2%

Maternal age (years)

• Composite complication rate:
-

 ervical, uterine, or intraabdominal injury
C
Fever
Hemorrhage (EBL>500)
Transfusion
Need for additional surgery (cervical repair, uterine
curettage, hysterectomy, laparotomy)
- Need for additional antibiotics
- Unexpected admission or readmission
- Maternal death

•	Serious complications were defined as transfusion,
uterine injury (cervical laceration, perforation),
readmission and maternal death
Table 2. Primary Indication for Uterine Evacuation
D&E
(n=94)

Ethnicity

Private Insurance
Multiparous

68%
59%

54%
57%

0.25

0.03
0.79

BMI (kg/m )

27.7±6.7

28.8±6.7

0.19

GA at procedure (weeks)

17.4±3.0

19.7±2.3

<0.001

Previous uterine surgery

15%

14%

0.90

6%

9%

0.52

86%

30%

<0.001

2

Previous LEEP/cone
Cervical ripening prior to
procedure

Data in mean ± SD or %. D&E; dilation and evacuation. BMI; body mass
index. GA; gestational age. LEEP; loop electrosurgical excision procedure.

Table 3. Procedure Outcome and Complications

Induction
(n=127)

D&E
(n=94)

Induction
(n=127)

P-value

14 (15%)

35 (28%)

0.03

7 (7%)

4 (3%)

0.15

13 (14%)

8 (6%)

0.06

Transfusion

1 (1%)

2 (2%)

0.75

Chorioamnionitis

4 (4%)

10 (8%)

0.28

2 (2%)
5 (5%)
1 (1%)

28 (22%)
0 (0%)
0 (0%)

<0.001
0.01
0.25

2 (2%)

2 (2%)

0.76

5.7 (2.6-241.7)

28.4 (11.0-173.0)

<0.001

Composite Complication Rate*
Serious Complication Rate**
EBL>500

Additional surgery required
Dilation and curettage
Repair of cervical laceration
Repair of uterine perforation

Readmission
Length of Stay (median hours)

Data is in n (%) or median (range), as indicated. EBL, estimated blood loss.
* Composite Complication Rate - hemorrhage (EBL>500), transfusion, chorioamnionitis,
need for additional surgery, unexpected admission or readmission.
** Serious Complication rate - transfusion, repair of uterine injury, readmission.

P-value

Fetal Demise

23%

37%

0.03

Chromosomal or Genetic
Abnormality

46%

11%

<0.001

Structural Abnormality

27%

44%

0.13

Maternal Medical Condition

3%

1%

0.19

Other*

1%

15%

<0.001

Data in %. *PPROM (preterm premature rupture of membranes),
oligohydramnios, growth restriction, or viral infection.

Conclusions:
•	Although both induction and D&E are safe methods for
midtrimester uterine evacuation, D&E is associated with
a lower composite complication rate, primarily due to
a high rate of unplanned dilation and evacuation in the
induction group.
•	D&E may be more cost effective than prostaglandin
induction of labor for midtrimester uterine evacuation
due to significantly shorter length of stay.

